Post by
NorCalTommy on Jun 16, 2021 5:40pm
Theralase current status
Sorry i haven't been following the message board for awhile but love the TLT story, recently had a big position and hopefully buying back soon... I came across your post Eoganacht... and i found myself wondering if the Theralase story is still as exciting and ready to pop, with the obstacles you mention below regarding Photosensitizer uptake... is this considered a new discovery, did they not know this all along? Is TLT running into obstacles and conditions that they had not completely considered and factored into their therapy, or am i just making too much out of this excerpt below? Is it going to take a host of different applications/procedures by TLT instead of a much more defined and 2x per year frequency treatement that seemed uber elegant and very simple..... now it appears that there are lots of variables.... but again i am not close to expert on these therapies... so i would be very interested in your take (Fred, Cancer Slayer, EOG, and the 'extremely knowledgeable crowd') on how you believe TLT is currently doing? are they 'on plan' or in the middle of 'course corrections/mods/revs' to make the PDT treatment more effective??
Thanks immensely in advance!!
EOGANACHT's Post Excerpt:
It’s acknowledged that the inter- and intra-patient variability of the tissue optical properties and the photosensitizer uptake remains a major obstacle to fully exploit the dual selectivity of PDT, resulting even with the application of precision PDT treatment planning in highly variable treatment outcomes. Enabling personalized PDT treatment planning requires the ability to quantify or predict the locally variable tissue optical properties, photosensitizer accumulation and oxygen availability
Comment by
Eoganacht on Jun 16, 2021 8:15pm
I think Theralase is doing great and that we will be happy with the phase 2 results despite the false start. Dr. Lilge is a perfectionist and is doing everything in his power to optimize the treatment. He keeps pushing because "good enough" is just not part of his vocabulary.
Comment by
Yajne on Jun 16, 2021 10:46pm
Also great to see that under ACT tab they are describing both GBM and NSCLC as "late preclinical". Expect that further details shared about status of these at the upcoming AGM. What does "late preclinical" really mean in terms of timing to kick off Ph1b trials?
Comment by
StevenBirch on Jun 17, 2021 8:09am
My guess is once they make their NMIBC submission to the FDA we could get news on that. They did say when Phase II was 'well underway' so I think that would qualify.
Comment by
Eoganacht on Jun 16, 2021 11:56pm
I think so, even though Dr. Lilge is writing here about precision PDT treatment planning in general, it's applicable to Theralase's treatments.
Comment by
Longholder99 on Jun 17, 2021 8:30am
The new standard of care for many types of cancer in the near future....and Lothar Lilge knows it. Ive been continuing to accumulate. Many thanks to the strong contributors here.
Comment by
Eoganacht on Jun 17, 2021 10:57am
Dr. Lilge is part of the team trying to make this happen. His research focus is on making oncological photodynamic therapy in general more practical and effective. And right now Theralase is the only game in town.
Comment by
fredgoodwinson on Jun 17, 2021 5:14pm
Thanks CS - Eoganacht mentioned that Prof.McFarland had suggested the possibility of down-converting x-ray photons to visible light photons in such a way and it is encouraging to think that she may be working with Dr.Lilge on this right now.
Comment by
NorCalTommy on Jun 16, 2021 11:32pm
Thanks much for your input Eoganacht! comforting indeed..... just a matter of waiting NCT